ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 28 No. 7 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

In Brief: House Money Bill Reportedly Will Not Increase

September 18, 1981

In Brief: Masnyk Named DCBD Deputy Director Maizel to Head NCI’s “Supercomputer” Development

November 2, 1984

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992